Drug firm Wockhardt today said that the UK health regulator has confirmed that its manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).
"UK MHRA (UK Medicines and Healthcare products Regulatory Agency) has since confirmed that general compliance with the principles and guidelines of Good Manufacturing Practice of the company's manufacturing unit at L-1, Chikalthana, Aurangabad," Wockhardt said in a filing to BSE
In view of this, the approval status of the said unit continues, it added.
Also Read
"Further, UK MHRA has considered the said manufacturing unit suitable for risk based inspection with reduced inspection frequency of two years from the existing inspection frequency of 1 year," Wockhardt said.
Shares of Wockhardt Ltd today closed at Rs 681.90 per scrip on BSE, down 0.45 per cent from previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
